{"context":{"query":">>efo>>gwas_study","source_dataset":"efo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0003884,72,EFO:0003884,123,0]["},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"EFO:0003884","source":"EFO:0003884|chronic kidney disease","targets":["GCST000020|End-stage renal disease|Hanson RL|Diabetes|2007-04-01","GCST000397|Renal function and chronic kidney disease|Kottgen A|Nat Genet|2009-05-10","GCST000518|End-stage renal disease|Craig DW|Diabet Med|2009-11-01","GCST000649|Chronic kidney disease|Kottgen A|Nat Genet|2010-04-11","GCST000696|End-stage renal disease (non-diabetic)|Bostrom MA|Hum Genet|2010-06-08","GCST000742|Chronic kidney disease and serum creatinine levels|Gudbjartsson DF|PLoS Genet|2010-07-29","GCST001066|Dialysis-related mortality|Murea M|Am J Nephrol|2011-05-05","GCST001107|End-stage renal disease|Freedman BI|PLoS Genet|2011-06-16","GCST001466|Chronic kidney disease|Pattaro C|PLoS Genet|2012-03-29","GCST001924|Chronic kidney disease|Yamada Y|J Med Genet|2013-03-28","GCST002182|End-stage renal disease in Type 1 diabetics|Sandholm N|J Am Soc Nephrol|2013-09-12","GCST002313|Chronic kidney disease|Nanayakkara S|J Occup Health|2013-12-18","GCST002464|End-stage renal disease or diabetic nephropathy in type 1 diabetes|Sambo F|Diabetologia|2014-05-29","GCST002720|Kidney function decline traits|Gorski M|Kidney Int|2014-12-10","GCST003140|Chronic kidney disease|Wuttke M|Nephrol Dial Transplant|2015-09-28","GCST003141|Proteinuria and chronic kidney disease|Wuttke M|Nephrol Dial Transplant|2015-09-28","GCST003374|Chronic kidney disease|Pattaro C|Nat Commun|2016-01-21","GCST003861|Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003862|Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003863|Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003864|Kidney disease (early and late stages) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003865|Kidney disease (early stage) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003866|Kidney disease (late stage) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST003867|Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes|Sandholm N|J Am Soc Nephrol|2016-09-19","GCST005427|End stage renal failure in renal transplantation (recipient effect)|Hernandez-Fuentes MP|Am J Transplant|2018-02-01","GCST005880|Chronic kidney disease in diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005882|Chronic kidney disease in type 2 diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005883|Chronic kidney disease and diabetic kidney disease in type 2 diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005884|Chronic kidney disease and diabetic kidney disease in diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005885|End-stage renal disease in type 2 diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005886|End-stage renal disease in diabetes|van Zuydam NR|Diabetes|2018-04-27","GCST005893|Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)|van Zuydam NR|Diabetes|2018-04-27","GCST006391|Chronic kidney disease|Hishida A|Am J Nephrol|2018-05-18","GCST006813|End stage renal disease x APOL1 genotype interaction|Langefeld CD|Kidney Int|2018-06-06","GCST006814|End-stage renal disease|Langefeld CD|Kidney Int|2018-06-06","GCST006815|End stage renal disease in APOL1 risk genotype-negative individuals|Langefeld CD|Kidney Int|2018-06-06","GCST006816|End stage renal disease in APOL1 risk genotype-positive individuals|Langefeld CD|Kidney Int|2018-06-06","GCST007734|Incident chronic kidney disease|Yun S|Clin Exp Nephrol|2019-04-06","GCST007879|Chronic kidney disease|Graham SE|Nat Commun|2019-04-23","GCST007920|Chronic kidney disease|Yasukochi Y|Mol Genet Genomics|2017-11-09","GCST008026|Chronic kidney disease|Wojcik GL|Nature|2019-06-19","GCST008031|End-stage renal disease|Wojcik GL|Nature|2019-06-19","GCST008064|Chronic kidney disease|Wuttke M|Nat Genet|2019-05-31","GCST008065|Chronic kidney disease|Wuttke M|Nat Genet|2019-05-31","GCST008394|Mild to moderate chronic kidney disease|Lin BM|Front Genet|2019-05-24","GCST008395|End-stage kidney disease|Lin BM|Front Genet|2019-05-24","GCST010478|Chronic kidney disease|Yamada Y|Int J Mol Med|2018-09-04","GCST010552|Chronic kidney disease x type 2 diabetes interaction|Vujkovic M|Nat Genet|2020-06-15","GCST011760|Kidney function traits (multivariate analysis)|Turchin MC|PLoS Genet|2019-10-09","GCST90018570|Acute renal failure|Sakaue S|Nat Genet|2021-09-30","GCST90018602|Chronic renal failure|Sakaue S|Nat Genet|2021-09-30","GCST90018790|Acute renal failure|Sakaue S|Nat Genet|2021-09-30","GCST90018822|Chronic renal failure|Sakaue S|Nat Genet|2021-09-30","GCST90044223|Chronic renal failure [CKD] (PheCode 585.3)|Jiang L|Nat Genet|2021-11-04","GCST90080581|ICD10 N18.3: Chronic kidney disease, stage 3 (moderate)|Backman JD|Nature|2021-10-18","GCST90080582|ICD10 N18.4: Chronic kidney disease, stage 4 (severe)|Backman JD|Nature|2021-10-18","GCST90080583|ICD10 N18.9: Chronic kidney disease, unspecified|Backman JD|Nature|2021-10-18","GCST90080584|ICD10 N18: Chronic kidney disease|Backman JD|Nature|2021-10-18","GCST90081467|Chronic kidney disease|Backman JD|Nature|2021-10-18","GCST90084567|ICD10 N18.3: Chronic kidney disease, stage 3 (moderate) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90084568|ICD10 N18.4: Chronic kidney disease, stage 4 (severe) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90084569|ICD10 N18.9: Chronic kidney disease, unspecified (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90084570|ICD10 N18: Chronic kidney disease (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90085453|Chronic kidney disease (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90091243|Chronic kidney disease|Horimoto A|J Am Soc Nephrol|2021-10-20","GCST90128454|Chronic kidney disease|Johnson R|Genome Med|2022-09-09","GCST90128464|Chronic kidney disease|Johnson R|Genome Med|2022-09-09","GCST90244130|End stage renal disease x APOL1 risk status (additive) interaction|Chaudhary NS|Front Med (Lausanne)|2022-09-28","GCST90244131|End stage renal disease x APOL1 risk status (recessive) interaction|Chaudhary NS|Front Med (Lausanne)|2022-09-28","GCST90246180|ICD10 N18: Chronic kidney disease|Walters RG|Cell Genom|2023-07-20","GCST90277418|Chronic kidney disease|Kim HR|Metabolites|2023-04-10","GCST90297591|ICD10 N18: chronic kidney disease (CNV mirror model)|Auwerx C|Genome Med|2024-01-08","GCST90297645|ICD10 N18: chronic kidney disease (CNV U-shape model)|Auwerx C|Genome Med|2024-01-08","GCST90297695|ICD10 N18: chronic kidney disease (CNV duplication-only model)|Auwerx C|Genome Med|2024-01-08","GCST90297739|ICD10 N18: chronic kidney disease (CNV deletion-only model)|Auwerx C|Genome Med|2024-01-08","GCST90436069|Hypertensive chronic kidney disease (PheCode 401.22)|Zhou W|Nat Genet|2018-08-13","GCST90474174|ICD10 N18: Chronic renal failure|UK Biobank Whole-Genome Sequencing Consortium|Nature|2025-08-06","GCST90474175|ICD10 N18: Chronic renal failure|UK Biobank Whole-Genome Sequencing Consortium|Nature|2025-08-06","GCST90474176|ICD10 N18: Chronic renal failure|UK Biobank Whole-Genome Sequencing Consortium|Nature|2025-08-06","GCST90474177|ICD10 N18: Chronic renal failure|UK Biobank Whole-Genome Sequencing Consortium|Nature|2025-08-06","GCST90474641|Chronic kidney disease|Scholz M|Nat Commun|2024-01-18","GCST90474642|Chronic kidney disease|Scholz M|Nat Commun|2024-01-18","GCST90474643|Chronic kidney disease|Scholz M|Nat Commun|2024-01-18","GCST90475791|Anemia in chronic kidney disease (PheCode 285.21)|Verma A|Science|2024-07-19","GCST90475792|Anemia in chronic kidney disease (PheCode 285.21)|Verma A|Science|2024-07-19","GCST90475926|Hypertensive chronic kidney disease (PheCode 401.22)|Verma A|Science|2024-07-19","GCST90475927|Hypertensive chronic kidney disease (PheCode 401.22)|Verma A|Science|2024-07-19","GCST90476125|End stage renal disease (PheCode 585.32)|Verma A|Science|2024-07-19","GCST90476126|End stage renal disease (PheCode 585.32)|Verma A|Science|2024-07-19","GCST90476127|Chronic Kidney Disease, Stage III (PheCode 585.33)|Verma A|Science|2024-07-19","GCST90476128|Chronic Kidney Disease, Stage III (PheCode 585.33)|Verma A|Science|2024-07-19","GCST90476129|Chronic Kidney Disease, Stage IV (PheCode 585.34)|Verma A|Science|2024-07-19","GCST90476130|Chronic Kidney Disease, Stage IV (PheCode 585.34)|Verma A|Science|2024-07-19","GCST90477461|Anemia in chronic kidney disease (PheCode 285.21)|Verma A|Science|2024-07-19","GCST90477854|Hypertensive chronic kidney disease (PheCode 401.22)|Verma A|Science|2024-07-19","GCST90478527|End stage renal disease (PheCode 585.32)|Verma A|Science|2024-07-19","GCST90478528|Chronic Kidney Disease, Stage III (PheCode 585.33)|Verma A|Science|2024-07-19","GCST90478529|Chronic Kidney Disease, Stage IV (PheCode 585.34)|Verma A|Science|2024-07-19","GCST90478530|Chronic kidney disease, Stage I or II (PheCode 585.4)|Verma A|Science|2024-07-19","GCST90478531|Chronic kidney disease, Stage I or II (PheCode 585.4)|Verma A|Science|2024-07-19"]}]}